Practice
Featured experience
Cerebras Systems $6.4 billion IPO
We advised the underwriters on the IPO
Alphabet $20 billion notes offering
We advised the global coordinators and book-running managers on the offering
Arxis $1.3 billion IPO
We advised Arxis on its IPO
Novartis $11 billion notes offering
We advised Novartis on the investment-grade debt offering
Export Development Canada $2 billion global bond offering
We advised the underwriters on the offering
Netflix $1 billion senior notes offering
We advised the joint book-running managers and underwriters on the offering
Inotiv emerges from chapter 11
We advised an ad hoc group of first-lien lenders in connection with Inotiv’s chapter 11 proceedings
MiniMax concurrent HK$16.04 billion placement of shares and convertible bonds
We advised MiniMax on its concurrent placement of new Class A shares and convertible bonds issuance
REGENXBIO $115 million equity offering
We advised the joint book-running managers and underwriters on the offering
Ascentage Pharma $200 million at-the-market offering
We advised the sales agents on the offering
GenFleet Therapeutics HK$471.8 million placement of new H shares
We advised GenFleet Therapeutics on the placement
Penguin Solutions $750M convertible notes offering and capped call transactions
We advised the initial purchasers on the offering
Standard Nuclear $150 million IPO
We advised the underwriters on the IPO
Uniti Group $1.1 billion fiber securitization notes offering
We advised Uniti on its second fiber-to-the-home securitization notes offering